A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection

PLoS Pathogens

Volumn 7, Issue 7, 2011, Pages

  Crawford, Alison ^a   Angelosanto, Jill Marie ^a   Nadwodny, Kim Lynn ^b   Blackburn, Shawn D ^a   Wherry, E John ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES; CCL5 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR5;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; DISEASE SEVERITY; FLOW CYTOMETRY; IN VITRO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; VIRUS INFECTION; VIRUS LOAD; WILD TYPE; ANIMAL; CHRONIC DISEASE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE MUTANT; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ANIMALIA; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS; WEST NILE VIRUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; CHRONIC DISEASE; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, KNOCKOUT; RECEPTORS, CCR5; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 79960937640     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002098     Document Type: Article

References (58)

1. Sallusto F, Mackay CR, Lanzavecchia A, (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18: 593-620.
2. Esche C, Stellato C, Beck LA, (2005) Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125: 615-628.
3. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B, (1996) Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 156: 322-327.
4. Schall TJ, Bacon K, Toy KJ, Goeddel DV, (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671.
5. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, et al. (1992) RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176: 1489-1495.
6. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, et al. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-386.
7. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, et al. (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440: 890-895.
8. Matloubian M, Concepcion RJ, Ahmed R, (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056-8063.
9. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
10. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
11. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188: 2205-2213.
12. Saito T, Deskin RW, Casola A, Haeberle H, Olszewska B, et al. (1997) Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 175: 497-504.
13. Hao X, Kim TS, Braciale TJ, (2008) Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol 82: 4908-4919.
14. Culley FJ, Pennycook AM, Tregoning JS, Hussell T, Openshaw PJ, (2006) Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol 80: 4521-4527.
15. Matsukura S, Kokubu F, Kubo H, Tomita T, Tokunaga H, et al. (1998) Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 18: 255-264.
16. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
17. Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR, (2004) Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol 76: 886-895.
18. Grayson MH, Ramos MS, Rohlfing MM, Kitchens R, Wang HD, et al. (2007) Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol 179: 1438-1448.
19. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, et al. (2005) CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11: 1180-1187.
20. Kohlmeier JE, Miller SC, Smith J, Lu B, Gerard C, et al. (2008) The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29: 101-113.
21. Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, et al. (2005) Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202: 1087-1098.
22. Lim JK, McDermott DH, Lisco A, Foster GA, Krysztof D, et al. (2010) CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 201: 178-185.
23. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
24. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, et al. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149-1158.
25. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, et al. (2007) CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 8: 1324-1336.
26. Fatkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, et al. (2005) Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med 11: 1170-1172.
27. Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, et al. (2006) CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203: 35-40.
28. Kindberg E, Mickiene A, Ax C, Akerlind B, Vene S, et al. (2008) A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 197: 266-269.
29. Asensio VC, Campbell IL, (1997) Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 71: 7832-7840.
30. Mueller SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, et al. (2007) Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670-674.
31. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R, (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911-4927.
32. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
33. Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, et al. (2004) The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285: 25-40.
34. Shedlock DJ, Shen H, (2003) Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
35. Sun JC, Bevan MJ, (2003) Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
36. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, et al. (2005) CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
37. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
38. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37.
39. Zhou S, Halle A, Kurt-Jones EA, Cerny AM, Porpiglia E, et al. (2008) Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol 194: 70-82.
40. Eberlein J, Nguyen TT, Victorino F, Golden-Mason L, Rosen HR, et al. (2010) Comprehensive assessment of chemokine expression profiles by flow cytometry. J Clin Invest 120: 907-923.
41. Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, et al. (2004) Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20: 219-230.
42. Fuller MJ, Khanolkar A, Tebo AE, Zajac AJ, (2004) Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol 172: 4204-4214.
43. Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, et al. (1994) Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A 91: 10854-10858.
44. Leist TP, Eppler M, Zinkernagel RM, (1989) Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J Virol 63: 2813-2819.
45. Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, et al. (1997) Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol 27: 2626-2633.
46. Matloubian M, Somasundaram T, Kolhekar SR, Selvakumar R, Ahmed R, (1990) Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J Exp Med 172: 1043-1048.
47. Bacon KB, Premack BA, Gardner P, Schall TJ, (1995) Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
48. Molon B, Gri G, Bettella M, Gomez-Mouton C, Lanzavecchia A, et al. (2005) T cell costimulation by chemokine receptors. Nat Immunol 6: 465-471.
49. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
50. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, et al. (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745.
51. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH, (2003) Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 100: 15818-15823.
52. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, et al. (2008) Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321: 408-411.
53. Galvani AP, Slatkin M, (2003) Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci U S A 100: 15276-15279.
54. Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, et al. (2008) Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 198: 500-507.
55. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
56. Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM, (2007) Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. J Gastroenterol Hepatol 22: 1510-1518.
57. Alter MJ, (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6-9.
58. Zeremski M, Petrovic LM, Talal AH, (2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14: 675-687.